Fresenius SE & Co. KGaA
Provides critical biopharma, medtech, and hospital care for critically & chronically ill patients.
FRE | F
Overview
Corporate Details
- ISIN(s):
- CH1298665980 (+4 more)
- LEI:
- XDFJ0CYCOO1FXRFTQS51
- Country:
- Germany
- Address:
- Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe
- Website:
- https://www.fresenius.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Fresenius SE & Co. KGaA is a global healthcare company providing system-critical products and services for the care of critically and chronically ill patients. The Group comprises two primary operating companies, Fresenius Kabi and Fresenius Helios, and holds a strategic investment in Fresenius Medical Care. Fresenius Kabi specializes in a wide range of biopharmaceuticals, clinical nutrition, medical technologies, and intravenous generic drugs. Fresenius Helios is a leading private hospital and outpatient care operator in Germany and Spain. Through its #FutureFresenius strategic program, the company is focused on strengthening its core platforms—(Bio)Pharma, MedTech, and Care Provision—to drive innovation and long-term growth.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-06 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 719.4 KB | ||
| 2025-07-04 08:03 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 77.9 KB | ||
| 2025-06-20 11:34 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 16.2 KB | ||
| 2025-05-07 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 1.4 MB | ||
| 2025-04-24 00:00 |
Annual Report
Annual financial report 2024
|
English | 11.6 MB | ||
| 2025-04-17 00:00 |
Governance Information
Corporate Governance Declaration and Report 2024 of Fresenius SE & Co. KGaA
|
English | 618.6 KB | ||
| 2025-04-09 15:05 |
Pre-Annual General Meeting Information
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting …
|
English | 3.6 KB | ||
| 2025-04-02 14:40 |
Director's Dealing
Fresenius SE & Co. KGaA: Robert Moller, buy
|
English | 6.5 KB | ||
| 2025-04-01 16:16 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 16.1 KB | ||
| 2025-04-01 14:22 |
Director's Dealing
Fresenius SE & Co. KGaA: Sara Hennicken, buy
|
English | 6.5 KB | ||
| 2025-03-24 16:09 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 72.3 KB | ||
| 2025-03-21 18:10 |
Major Shareholding Notification
|
English | 72.3 KB | ||
| 2025-03-06 18:55 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 72.4 KB | ||
| 2025-03-04 18:03 |
M&A Activity
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
|
English | 18.0 KB | ||
| 2025-03-03 18:03 |
Major Shareholding Notification
Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake …
|
English | 18.0 KB |
Automate Your Workflow. Get a real-time feed of all Fresenius SE & Co. KGaA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Fresenius SE & Co. KGaA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-01-19 | Laumann, Johannes | Board | Other | None | 68,475.00 EUR |
| 2021-11-15 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | None | 20,300.00 EUR |
| 2021-11-11 | De Meo, Dr. Francesco | Board | Sell | None | 190,786.85 EUR |
| 2021-11-10 | Riedel, Oliver | Board | Buy | None | 10,896.40 EUR |
| 2021-11-10 | RAT Asset & Trading GmbH | Close relation | Buy | None | 14,400.00 EUR |
| 2021-11-09 | Kassow, Dr. Achim | Board | Buy | None | 50,520.75 EUR |
| 2021-11-09 | Gartside, Nicholas | Board | Buy | None | 189,900.00 EUR |
| 2021-11-08 | Neuroth, Hans Peter | Board | Buy | None | 76,400.00 EUR |
| 2021-11-05 | Sturm, Stephan | Board | Other | None | 1,778,714.95 EUR |
| 2021-08-04 | De Meo, Dr. Francesco | Board | Sell | None | 451,130.17 EUR |
